Indian drugmaker Aurobindo Pharma reported a lower third-quarter profit on Thursday, as a spike in expenses more than offset strong demand for its generic drugs.

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

India's apex drug advisory body has been inactive since its term ended in October. This was brought to the health ministry's ...

Sun Pharmaceutical , India's largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided ...

Indian pharmaceutical companies lag behind global peers in ESG practices, facing regulatory, awareness, and resource ...

Any tariffs on India or potential onshoring in US would be counterproductive, increasing the prices for US generics created ...

India's trade surplus with the US and its reliance on American trade policy for US dollar earnings make it a key player.

Shares of Abbott India surged 5.60% higher at ₹27,605.45 on the BSE on Tuesday. The pharma stock reacted positively to the ...

Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...

The Union Budget 2025 has waived import duty on 36 life-saving drugs and reduced it for six others. While this is expected to ...

By Kashish Tandon and Rishika Sadam HYDERABAD/BENGALURU (Reuters) -Sun Pharmaceutical, India's largest drugmaker by revenue, ...